KHPG(SZ:002773) Xin Lang Cai Jing·2025-11-12 02:03Core Viewpoint - Kanghong Pharmaceutical has shown a significant stock price increase of 69.79% year-to-date, with a recent market capitalization of 29.72 billion yuan, indicating strong investor interest and potential growth in the pharmaceutical sector [1][2]. Financial Performance - For the period from January to September 2025, Kanghong Pharmaceutical reported a revenue of 3.624 billion yuan, reflecting a year-on-year growth of 6.23%, while the net profit attributable to shareholders was 1.033 billion yuan, up by 6.08% [2]. - The company has distributed a total of 2.038 billion yuan in dividends since its A-share listing, with 1.04 billion yuan distributed over the past three years [3]. Shareholder Information - As of October 20, 2025, the number of shareholders for Kanghong Pharmaceutical increased to 24,900, a rise of 3.53%, while the average number of tradable shares per shareholder decreased by 3.41% to 27,592 shares [2]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 28.007 million shares, an increase of 730,000 shares from the previous period [3].